IP Library Granted Patent US 11,174,223
Granted Patent B2
US 11,174,223 · App. 15/593,540 · Granted Nov 16, 2021

Compositions, methods, and systems for the synthesis and use of imaging agents

Inventors: Ajay Purohit (Sudbury, MA); Pedro Benites (Watertown, MA); Heike S. Radeke (South Grafton, MA); Joel Lazewatsky (Auburndale, MA); L. Veronica Lee (Carlisle, MA)
Assignee: Lantheus Medical Imaging, Inc.
C07C303/30A61K51/04A61K51/0406C07B59/001C07C53/06C07C53/10C07C53/18C07C63/08C07C213/02C07C217/58C07C255/54C07C277/08C07C279/10C07C279/24C07C303/28C07C309/04C07C309/30C07C309/65C07C309/66C07C309/73A61K51/00C07B2200/05C07C277/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,174,223
App. No.
15/593,540
Granted
Nov 16, 2021
Kind
B2
Abstract

The present invention generally relates to novel synthetic methods, systems, kits, salts, and precursors useful in medical imaging. In some embodiments, the present invention provides compositions comprising an imaging agent precursor, which may be formed using the synthetic methods described herein. An imaging agent may be converted to an imaging agent using the methods described herein. In some cases, the imaging agent is enriched in 18 F. In some cases, an imaging agent including salt forms (e.g., ascorbate salt) may be used to image an area of interest in a subject, including, but not limited to, the heart, cardiovascular system, cardiac vessels, brain, and other organs.

Claims (13)

1. An ascorbate salt of formula (VII):

wherein X ⊖ is ascorbate, optionally, wherein the fluorine is isotopically enriched with 18 F.

2. A pharmaceutically acceptable composition comprising the salt of claim 1 , and optionally a pharmaceutically acceptable excipient.

3. A composition comprising the salt of claim 1 for imaging a portion of a subject.

4. A method of imaging a subject, comprising:

administering a dose of a pharmaceutically acceptable composition comprising the salt of claim 1 and optionally a pharmaceutically acceptable excipient; and

acquiring at least one image of a portion of the subject.

5. The method of claim 4 , wherein the maximum dose of the salt is approximately 13 mCi or less.

6. The method of claim 4 , wherein the dose is between 8 mCi and 13 mCi.

7. The method of claim 4 , wherein the portion of the subject is at least a portion of the cardiovascular system, at least a portion of the heart, or at least a portion of a tumor.

8. A method for detecting norepinephrine transporter (NET) in a portion of a subject, the method comprising:

administering a dose of a pharmaceutically acceptable composition comprising the salt of claim 1 and optionally a pharmaceutically acceptable excipient; and

acquiring at least one image of the portion of the subject, wherein the image detects NET in the subject.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Dec 2, 2022
From: WELLS FARGO BANK, N.A.
To: LANTHEUS MEDICAL IMAGING, INC.
Reel/Frame 062047/0925 →
SECURITY INTEREST Recorded Dec 2, 2022
From: LANTHEUS MEDICAL IMAGING, INC.; MOLECULAR INSIGHT PHARMACEUTICALS, INC.; PSMA DEVELOPMENT COMPANY, LLC; PROGENICS PHARMACEUTICALS, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 062047/0960 →
SECURITY AGREEMENT Recorded Jun 28, 2019
From: LANTHEUS MEDICAL IMAGING, INC.
To: WELLS FARGO BANK, N.A.
Reel/Frame 049628/0001 →
RELEASE OF SECURITY INTEREST Recorded Jun 27, 2019
From: JPMORGAN CHASE BANK, N.A.
To: LANTHEUS MEDICAL IMAGING, INC.
Reel/Frame 049623/0123 →
PATENT SECURITY AGREEMENT Recorded Apr 12, 2018
From: LANTHEUS MEDICAL IMAGING, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 045929/0908 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2018
From: PUROHIT, AJAY; BENITES, PEDRO; CHEESMAN, EDWARD H.; LAZEWATSKY, JOEL; LEE, L. VERONICA; CESATI, RICHARD R., III; LOOBY, RICHARD J.; RADEKE, HEIKE S.
To: LANTHEUS MEDICAL IMAGING, INC.
Reel/Frame 045062/0929 →
Continuity (6)
Continuation 15170848 · Jun 1, 2016
Division 13697287
Provisional Application 61405571 · Oct 21, 2010
Provisional Application 61405524 · Oct 21, 2010
Provisional Application 61333618 · May 11, 2010
Related Publication 20170355669A1 · Dec 14, 2017
Cited By (1)
US 12,324,845